Melanotan 1 (MT-1) is a synthetic peptide, specifically known as SCENESSE (afamelanotide), designed to stimulate melanin production for UV-induced skin tanning. Its primary benefits include promoting a deep tan with reduced sun exposure, providing increased photoprotection (reducing sunburn cells by up to 47%), and potential protection against UV-related skin damage.
Key Benefits of Melanotan 1:
- Enhanced Tanning: MT-1 significantly increases the production of eumelanin, the type of melanin that provides greater protection against UV radiation.
- Reduced Sunburn Risk: Studies indicate that users experience up to 47% fewer sunburn cells at UV-irradiated sites.
- Long-Lasting Results: Tanning effect from MT-1 can be maintained for several weeks longer than those achieved by sun exposure alone.
- Photoprotective Capabilities: It acts as a preventive agent against skin diseases, including erythropoietic protoporphyria, solar dermatitis, and polymorphic light eruption.
- Selective Action: Unlike Melanotan II, which is associated with more side effects, Melanotan 1 is more targeted at melanin production.
Important Considerations:
- Side Effects: Potential minor side effects include nausea and transient facial flushing.
- Method of Administration: It is typically administered via subcutaneous injection.
- Legal/Safety Warning: While Melanotan 1 is in advanced clinical trials (or approved in some contexts like SCENESSE), the Therapeutic Goods Administration (TGA) and other health bodies often advise caution regarding the safety of unregulated, online-sourced tanning injections, which are illegal to sell in some regions.
Clinical studies have demonstrated that Melanotan-1 can be safely combined with light, acting synergistically to provide a tanning response.
